University of Chicago’s Polsky Center for Entrepreneurship has formed microbiome-focused Avnovum Therapeutics, BiomeSense, Covira and Oxalo Therapeutics over the past year.

University of Chicago (UChicago)’s Polsky Center for Entrepreneurship has highlighted the founding of four US-based biotech spinouts focused on microbiome-based applications over the past year.
The companies include Avnovum Therapeutics, which is working on microbial peptides that help vitalise fungal microbiomes by preventing infection and virulence, and BiomeSense, which is developing an automated sensor that evaluates the microbial composition of air and water.
Avnovum Therapeutics builds on work by Eugene Chang, an associate section chief for research at the…

Subscribe to go deeper

GCV subscribers get access to all our proprietary data and deep-dive articles, as well as the global directory of CVC investors.

Not sure if you have a subscription?